All Commercialising the microbiome articles
-
NewsCould faecal microbiota transplantation help patients heal after stem cell transplantation?
A study, from a part of an ongoing clinical trial, has reported the safety of oral faecal microbiota transplantation (FMT) to help patients recover from the loss of gut microbiome after allogeneic stem cell transplantation for blood cancers.
-
CareersThe true cost of science
Discover valuable insights from three companies in the microbiology field, and their experience of balancing innovation, investment, and sustainability to drive their success.
-
NewsElderberry juice shows benefits for weight management, metabolic health
Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent study.
-
NewsFunding boost to bring engineering biology technologies to market
Part of a £2.8 million UKRI seed corn fund has been awarded to the Environmental Biotechnology Innovation Centre (EBIC) to bridge the gap between research and market-ready products and technologies, with comprehensive support and resources for researchers.
-
FeaturesUnder the microscope: commercialisation of the microbiome
Over the last decade, there has been a paradigm shift from investigating single organisms and single target treatments towards studying the totality of an environment.
-
FeaturesMetabolomics: decoding the chemical language of life
Imagine if we could explore the entire molecular universe in our bodies, interpreting the intricate chemical changes related to health and disease at its most fundamental level.
-
CareersFarm gates and facial fungi: Tanu charts her journey towards commercialisation
AMI Global Ambassador for New Zealand Tanushree Gupta is bringing an antifungal product to market that will make a huge difference to the hundreds of farms affected by facial eczema - so here’s how it’s going.
-
NewsBirmingham Drug Discovery Hub creates an investment-ready ‘drug library’
A novel approach to drug discovery is enabling University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment.
